TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Sana Pharma Medical AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
67,242
|
56,624
|
61,703 |
| Financial expenses |
3,181
|
1,420
|
1,047 |
| Earnings before taxes |
-9,844
|
-10,465
|
-664 |
| Total assets |
80,666
|
65,792
|
47,077 |
| Current assets |
63,451
|
46,918
|
28,948 |
| Current liabilities |
86,587
|
57,829
|
32,690 |
| Equity capital |
-5,921
|
3,922
|
14,387 |
| - share capital |
30
|
30
|
30 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-7.3%
|
6.0%
|
30.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-14.6%
|
-18.5%
|
-1.1% |
| Return on assets (ROA) |
-8.3%
|
-13.7%
|
0.8% |
| Current ratio |
73.3%
|
81.1%
|
88.6% |
| Return on equity (ROE) |
166.3%
|
-266.8%
|
-4.6% |
| Change turnover |
10,618
|
-5,079
|
-1,831 |
| Change turnover % |
19%
|
-8%
|
-3% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.